标题
Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma
作者
关键词
-
出版物
Cancers
Volume 13, Issue 16, Pages 4199
出版商
MDPI AG
发表日期
2021-08-23
DOI
10.3390/cancers13164199
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
- (2020) Dan Liao et al. NATURE CELL BIOLOGY
- Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid
- (2020) Mariah M. Hoffman et al. Cancers
- Apoptotic Effects of N-(2-hydroxyphenyl)-2-propylpentanamide on U87-MG and U-2 OS Cells and Antiangiogenic Properties
- (2020) Paola Castillo-Juárez et al. Anti-Cancer Agents in Medicinal Chemistry
- PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma
- (2020) Branden A. Smeester et al. BONE
- Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma
- (2020) Jeremy J. McGuire et al. INTERNATIONAL JOURNAL OF CANCER
- Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway
- (2020) Ashley VanCleave et al. Oncotarget
- The HDAC Inhibitor Domatinostat Promotes Cell Cycle Arrest, Induces Apoptosis and Increases Immunogenicity of Merkel Cell Carcinoma Cells
- (2020) Lina Song et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor
- (2020) Rui Han et al. Molecular Therapy-Oncolytics
- Tegavivint and the β-catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma
- (2019) Motonari Nomura et al. JNCI-Journal of the National Cancer Institute
- Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells
- (2019) Marion Wobser et al. Journal of Hematology & Oncology
- Podocyte histone deacetylase activity regulates murine and human glomerular diseases
- (2019) Kazunori Inoue et al. JOURNAL OF CLINICAL INVESTIGATION
- HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells
- (2019) Jing Li et al. CELL BIOLOGY AND TOXICOLOGY
- Metformin and 4SC‐202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma
- (2019) Yuan He et al. Cancer Medicine
- Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
- (2019) Ryan D. Roberts et al. CANCER
- Osteosarcoma in the Post Genome Era: Preclinical Models and Approaches to Identify Tractable Therapeutic Targets
- (2019) Wilson Castillo-Tandazo et al. Current Osteoporosis Reports
- Class I HDAC inhibitors enhance YB ‐1 acetylation and oxidative stress to block sarcoma metastasis
- (2019) Amal M El‐Naggar et al. EMBO REPORTS
- Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
- (2019) Jo Lynne Rokita et al. Cell Reports
- Trichostatin A activates FOXO1 and induces autophagy in osteosarcoma
- (2018) Yunjuan Bai et al. Archives of Medical Science
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
- (2018) James J Morrow et al. NATURE MEDICINE
- Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma
- (2018) K. Patatsos et al. Veterinary and Comparative Oncology
- Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
- (2018) Jay H. Kalin et al. Nature Communications
- Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates
- (2018) Shengdong Wang et al. Frontiers in Immunology
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
- (2018) Xiaotu Ma et al. NATURE
- Synergistic antitumor effect of suberoylanilide hydroxamic acid and cisplatin in osteosarcoma cells
- (2018) Mengyi Hou et al. Oncology Letters
- Genome-Informed Targeted Therapy for Osteosarcoma
- (2018) Leanne C Sayles et al. Cancer Discovery
- Panobinostat mediated cell death. A novel therapeutic approach for osteosarcoma
- (2018) André Wirries et al. Oncotarget
- Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies
- (2018) Bastian von Tresckow et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy
- (2018) Marcella La Noce et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
- (2018) Fang Fang et al. Oncotarget
- Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations
- (2018) Amos H.P. Loh et al. CANCER LETTERS
- Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance
- (2017) Wolfgang Gruber et al. INTERNATIONAL JOURNAL OF CANCER
- The Effect of VPA on Increasing Radiosensitivity in Osteosarcoma Cells and Primary-Culture Cells from Chemical Carcinogen-Induced Breast Cancer in Rats
- (2017) Guochao Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications
- (2017) Parunya Chaiyawat et al. MODERN PATHOLOGY
- Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner
- (2017) Vivek Kumar Mishra et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1
- (2017) Shi Ying et al. ONCOLOGY RESEARCH
- Epigenetic plasticity and the hallmarks of cancer
- (2017) William A. Flavahan et al. SCIENCE
- Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
- (2017) Chao Zhang et al. Oncotarget
- Whole-exome analysis in osteosarcoma to identify a personalized therapy
- (2017) Caterina Chiappetta et al. Oncotarget
- Down-regulation of HDAC3 inhibits growth of cholangiocarcinoma by inducing apoptosis
- (2017) Mingming Zhang et al. Oncotarget
- Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
- (2017) Simin Kiany et al. OncoImmunology
- 4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to inhibit hepatocellular carcinoma cells
- (2016) Meili Fu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation
- (2016) Zhantao Deng et al. International Journal of Biological Sciences
- The molecular hallmarks of epigenetic control
- (2016) C. David Allis et al. NATURE REVIEWS GENETICS
- The burden of musculoskeletal diseases in the United States
- (2016) Edward Yelin et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
- (2016) Maria Pinkerneil et al. Targeted Oncology
- Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells
- (2016) Huang Zhijun et al. TUMOR BIOLOGY
- Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2–p53 signaling
- (2016) Chuhai Xie et al. OncoTargets and Therapy
- Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression
- (2016) Heng Zeng et al. Oncotarget
- Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- (2016) Ivan Kopljar et al. Stem Cells Translational Medicine
- Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells
- (2015) KOJI YAMANEGI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma
- (2015) Milcah C. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor Cells
- (2015) Meghan E McGee-Lawrence et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Novel Histone Deacetylase Inhibitors Induce Growth Arrest, Apoptosis, and Differentiation in Sarcoma Cancer Stem Cells
- (2015) Gemma Di Pompo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling
- (2015) Jessica M Foley et al. Journal of Translational Medicine
- Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma
- (2015) Diana Yu et al. Scientific Reports
- The HDAC Inhibitor Vorinostat Diminishes theIn VitroMetastatic Behavior of Osteosarcoma Cells
- (2015) Xiaodong Mu et al. Biomed Research International
- Notch Activation as a Driver of Osteogenic Sarcoma
- (2014) Jianning Tao et al. CANCER CELL
- Wnt5a promotes migration of human osteosarcoma cells by triggering a phosphatidylinositol-3 kinase/Akt signals
- (2014) Ailiang Zhang et al. Cancer Cell International
- Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
- (2014) C. Khanna et al. CLINICAL CANCER RESEARCH
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
- (2014) Enrico Capobianco et al. PLoS One
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Tubulin polymerization promoting protein 1 (TPPP1) increases β-catenin expression through inhibition of HDAC6 activity in U2OS osteosarcoma cells
- (2013) Alice V. Schofield et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts
- (2013) Richard D.W. Kelly et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- FOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function
- (2013) I. Shats et al. CANCER RESEARCH
- Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
- (2013) Hernan Carol et al. PEDIATRIC BLOOD & CANCER
- Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage
- (2013) T Ozaki et al. Cell Death & Disease
- Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A in Osteosarcoma Cells
- (2012) Dong-Dong Cheng et al. Asian Pacific Journal of Cancer Prevention
- Histone deacetylase 3 is required for maintenance of bone mass during aging
- (2012) Meghan E. McGee-Lawrence et al. BONE
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Hdac-Mediated Control of Endochondral and Intramembranous Ossification
- (2012) Jennifer J. Westendorf et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)
- (2012) Jodi A. Muscal et al. PEDIATRIC BLOOD & CANCER
- Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation
- (2012) C. Blattmann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases
- (2011) Nadezhda V. Koshkina et al. CANCER
- One NOTCH Further: Jagged 1 in Bone Metastasis
- (2011) Jianning Tao et al. CANCER CELL
- Upregulation of Polo-like kinase 2 gene expression by GATA-1 acetylation in human osteosarcoma MG-63 cells
- (2011) Tao Shen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Dissection of Wnt5a-Ror2 Signaling Leading to Matrix Metalloproteinase (MMP-13) Expression
- (2011) Kaoru Yamagata et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma
- (2011) Luke A. Wittenburg et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Acetylation controls Notch3 stability and function in T-cell leukemia
- (2011) R Palermo et al. ONCOGENE
- Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells
- (2010) Cao Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Histone deacetylases in skeletal development and bone mass maintenance
- (2010) Meghan E. McGee-Lawrence et al. GENE
- Enhancement of Radiation Response in Osteosarcoma and Rhabomyosarcoma Cell Lines by Histone Deacetylase Inhibition
- (2010) Claudia Blattmann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
- (2010) Steven A. Harris et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice
- (2010) Sam D. Molyneux et al. JOURNAL OF CLINICAL INVESTIGATION
- Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity
- (2010) Yamanegi ONCOLOGY REPORTS
- Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model
- (2010) Jason T. Yustein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene ontology analysis for RNA-seq: accounting for selection bias
- (2010) Matthew D Young et al. GENOME BIOLOGY
- Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
- (2009) M Tanaka et al. BRITISH JOURNAL OF CANCER
- Notch signaling contributes to the pathogenesis of human osteosarcomas
- (2009) F. Engin et al. HUMAN MOLECULAR GENETICS
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
- (2009) Maya Kansara et al. JOURNAL OF CLINICAL INVESTIGATION
- Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
- (2009) M Enomoto et al. ONCOGENE
- Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program
- (2009) Nino Keshelava et al. PEDIATRIC BLOOD & CANCER
- Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell death
- (2008) Koji Yamanegi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Involvement of Extracellular Signal-Regulated Kinase Activation in Human Osteosarcoma Cell Resistance to the Histone Deacetylase Inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone]
- (2008) H. Matsubara et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started